Suppr超能文献

CYP17A1 基因 rs743572 上 GG 基因型调控 T/E 比值降低可作为 MetS-BPH 的独立危险因素:一项回顾性队列研究。

The GG genotype of rs743572 in CYP17A1 gene regulating the decrease of T/E ratio can be an independent risk factor for MetS-BPH: a retrospective cohort study.

机构信息

Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.

Department of Urology, People's Hospital of Wuchuan County, Wuchuan, Guizhou, 564300, China.

出版信息

World J Urol. 2024 Jul 24;42(1):439. doi: 10.1007/s00345-024-05138-3.

Abstract

PURPOSE

To confirm if the CYP17A1 gene regulates the ratio of T/E leading to MetS-BPH.

METHODS

824 men, aged 47-88 years, were recruited into this study through consecutive routine physical examination programs and long-term outpatient screening. Several parameters, including SNPs of CYP17A1 gene, total testosterone, estradiol, and the ratio of total testosterone to estradiol (T/E) were obtained for each participant. Based on the diagnosis of BPH, MetS, and MetS-BPH, the participants were divided into BPH and non-BPH groups, MetS and non-MetS groups, and MetS-BPH and non-MetS-BPH groups. Values of the obtained parameters were evaluated using one-way analysis of variance, Student's t-test, Chi-squared test, and logistic regression analysis.

RESULTS

SNPs of the CYP17A1 gene, including the rs743572 genotypes (GG, GA, and AA), rs3781287 genotypes (GG, GT, TT), and rs4919686 genotypes (CC, CA, and AA), were present in every group. Only the GG genotype of rs743572 was independently associated with BPH (OR = 5.868, 95% CI: 3.363-7.974, P < 0.001), MetS (OR = 7.228, 95% CI: 3.925-11.331, P < 0.001), and MetS-BPH (OR = 3.417, 95% CI: 1.783-5.266, P < 0.001) after adjusting for age. In the population of genotype GG of rs743572, the decrease in T/E ratio was an independent risk factor for BPH (OR = 839.756, 95% CI: 36.978-1334.263, P = 0.001), MetS (OR = 376.988, 95% CI: 12.980-488.976, P < 0.003), and MetS-BPH (OR = 388.236, 95% CI: 24.869-495.363, P = 0.003).

CONCLUSION

The GG genotype of rs743572 in CYP17A1 gene regulating the decrease of T/E ratio can be an independent risk factor for MetS-BPH populations.

TRIAL REGISTRATION NUMBER

ChiCTR2200057632 "retrospectively registered".

DATE OF REGISTRATION

March 15, 2022 "retrospectively registered".

摘要

目的

确认 CYP17A1 基因是否调节导致 MetS-BPH 的 T/E 比值。

方法

本研究通过连续的常规体检计划和长期门诊筛查,招募了 824 名年龄在 47-88 岁的男性。为每位参与者获得了 CYP17A1 基因的 SNPs、总睾酮、雌二醇和总睾酮与雌二醇(T/E)的比值等参数。根据 BPH、MetS 和 MetS-BPH 的诊断,将参与者分为 BPH 和非 BPH 组、MetS 和非 MetS 组以及 MetS-BPH 和非 MetS-BPH 组。使用单因素方差分析、学生 t 检验、卡方检验和 logistic 回归分析评估获得的参数值。

结果

CYP17A1 基因的 SNPs,包括 rs743572 基因型(GG、GA 和 AA)、rs3781287 基因型(GG、GT 和 TT)和 rs4919686 基因型(CC、CA 和 AA),存在于每个组中。只有 rs743572 的 GG 基因型与 BPH(OR=5.868,95%CI:3.363-7.974,P<0.001)、MetS(OR=7.228,95%CI:3.925-11.331,P<0.001)和 MetS-BPH(OR=3.417,95%CI:1.783-5.266,P<0.001)独立相关,在调整年龄后。在 rs743572 的 GG 基因型人群中,T/E 比值降低是 BPH(OR=839.756,95%CI:36.978-1334.263,P=0.001)、MetS(OR=376.988,95%CI:12.980-488.976,P<0.003)和 MetS-BPH(OR=388.236,95%CI:24.869-495.363,P=0.003)的独立危险因素。

结论

CYP17A1 基因 rs743572 的 GG 基因型调节 T/E 比值降低可作为 MetS-BPH 人群的独立危险因素。

临床试验注册号

ChiCTR2200057632 “回顾性注册”。

注册日期

2022 年 3 月 15 日 “回顾性注册”。

相似文献

5
Association between CYP17A1 rs3824755 and rs743572 gene polymorphisms and Alzheimer's disease in the Chinese Han population.
Neurosci Lett. 2016 Apr 8;618:77-82. doi: 10.1016/j.neulet.2016.02.053. Epub 2016 Mar 3.
7
The single-nucleotide polymorphism rs743572 of CYP17A1 shows significant association with polycystic ovary syndrome: a meta-analysis.
Reprod Biomed Online. 2021 Nov;43(5):941-951. doi: 10.1016/j.rbmo.2021.06.012. Epub 2021 Jun 23.
8
CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility: evidences from a case-control study.
Medicine (Baltimore). 2018 Jul;97(28):e11415. doi: 10.1097/MD.0000000000011415.

引用本文的文献

1
A scoping review of the role of heritability and environmental exposures in the development and severity of benign prostatic hyperplasia.
Transl Androl Urol. 2025 Aug 30;14(8):2439-2455. doi: 10.21037/tau-2025-342. Epub 2025 Aug 25.
2
The pathogenesis of benign prostatic hyperplasia and the roles of Prdx3, oxidative stress, pyroptosis and autophagy:a review.
Front Oncol. 2025 Aug 5;15:1579539. doi: 10.3389/fonc.2025.1579539. eCollection 2025.

本文引用的文献

4
Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats.
Environ Sci Pollut Res Int. 2022 Mar;29(14):20370-20378. doi: 10.1007/s11356-021-17245-4. Epub 2021 Nov 4.
6
Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance.
Andrologia. 2021 Jul;53(6):e14060. doi: 10.1111/and.14060. Epub 2021 Mar 30.
7
Using human genetics to understand the disease impacts of testosterone in men and women.
Nat Med. 2020 Feb;26(2):252-258. doi: 10.1038/s41591-020-0751-5. Epub 2020 Feb 10.
8
9
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Gerontology. 2019;65(5):458-464. doi: 10.1159/000496289. Epub 2019 Apr 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验